Micromedic Technologies / Dr. Lal PathLabs Pilot

Micromedic Technologies has created CellDetect®, a staining technology that combines color and morphology to screen women who are at risk of developing cervical cancer. In this pilot, cervical specimens collected at Dr. Lal PathLabs were analyzed using CellDetect® to simplify and expedite the interpretation of microscopic slides and boost the detection of early stage and pre-cancer lesions.

transmuralcloudnine (1).png

Pilot Duration

March 2017- December 2017

Location

Dr. Lal PathLabs Ltd. National Reference Laboratory, Rohini, New Delhi, India

 

Results

  • 170 patients enrolled

  • CellDetect® color feature and its ability to highlight endocervical/abnormal cells was considered a useful tool for both negative and suspicious cases.

  • Adding color discrimination to morphology in slide analysis improved efficiency of screening process. Turnaround time per slide was 34% shorter with CellDetect® than with Pap. 

Lessons Learned

The pilot highlighted CellDetect’s capabilities and also demonstrated that remote training and technical support are effective and sufficient.  

The pilot enabled Micromedic to learn how to navigate regulatory and import requirements and collect local data in India. The pilot also helped the company know the applicability of their other products, including applications related to bladder cancer. Based on local evidence and experience accumulated through the pilot, Micromedic has signed a local partner to distribute their products in India.    

9.png
Micromed LPL.PNG
 
Micromed LPL Cell Color.PNG